The neuropsychiatric profile of Parkinson's disease subjects with and without mild cognitive impairment

Journal of Neural Transmission

Volumn 120, Issue 4, 2013, Pages 607-611

  Monastero, Roberto ^a   Di Fiore, Paola ^a   Ventimiglia, Giusi D ^a   Camarda, Rosolino ^a   Camarda, Cecilia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cognitive impairment; Epidemiology; Neuropsychiatric symptoms; Parkinson's disease

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; LEVODOPA; NEUROLEPTIC AGENT;

ADULT; AGED; ANXIETY DISORDER; APATHY; CONFERENCE PAPER; DEPRESSION; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRY; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEP DISORDER;

AGED; AMNESIA; COGNITION; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 84875723833     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-0988-y     Document Type: Conference Paper

References (25)

1. Aarsland D, Marsh L, Schrag A (2009) Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 24:2175-2186
2. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV (text revision). American Psychiatric Association, Washington
3. Appollonio I, Leone M, Isella V et al (2005) The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108-116 (Pubitemid 40975511)
4. Carlesimo GA, Caltagirone C, Gainotti G (1996) The mental deterioration battery: normative data, diagnostic reliability and quantitative analyses of cognitive impairment. Eur Neurol 36:378-384 (Pubitemid 26343685)
5. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308-2314 (Pubitemid 24382728)
6. Fahn S, Marsden CD, Calne DB, Goldstein M (eds) (1987) Recent developments in Parkinson's Disease, vol 2. Macmillan Health Care Information, Florham Park, pp 153-163
7. Folstein MF, Folstein SE, McHugh PR (1975) 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
8. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E (1996) Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci 17:305-309 (Pubitemid 126764956)
9. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427-442
10. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572 (Pubitemid 12124384)
11. Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993) A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 50:140-148 (Pubitemid 23054795)
12. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914-919
13. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179-186
14. Leroi I, Pantula H, McDonald K, Harbishettar V (2012) Neuropsychiatric symptoms in Parkinson's disease with mild cognitive impairment and dementia. Parkinsons Dis 2012:308097
15. Litvan I, Aarsland D, Adler CH et al (2011) MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 26:1814-1824
16. Litvan I, Goldman JG, Tröster AI et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov Disord 27:349-356
17. Luzzatti C, Willmes K, De Bleser R et al (1994) New normative data for the Italian version of the Aachen Aphasia Test (AAT). Arch Psicol Neurol Psichiatria 55:1086-1131
18. Mariani E, Monastero R, Mecocci P (2007) Mild cognitive impairment: a systematic review. J Alzheimers Dis 12:23-35 (Pubitemid 47396302)
19. Monastero R, Di Fiore P, Ventimiglia GD et al (2012) Prevalence and profile of mild cognitive impairment in Parkinson's disease. Neurodegener Dis 10:187-190
20. Parmelee PA, Thuras PD, Katz IR, Lawton MP (1995) Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc 43:130-137
21. Spinnler H, Tognoni G (1987) Italian group on the neuropsychological study of ageing: Italian standardization and classification of neuropsychological tests. Ital J Neurol Sci 6(suppl 8):1-120
22. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649-2653
23. Warrington EK, James M (1991) The visual object and space perception battery. Thames Valley Test Company, Bury St. Edmunds
24. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2012. Oslo, 2011
25. Winblad B, Palmer K, Kivipelto M et al (2004) Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256:240-246 (Pubitemid 39222993)